Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Some people taking glucagon-like peptide 1 (GLP-1) receptor agonists a type of medication used to support weight loss and manage type 2 diabetes experience gastrointestinal (GI) side effects, including diarrhea
While these findings are observational and require confirmation in prospective studies, they highlight the potential of GLP-1 therapies to influence long-term musculoskeletal and inflammatory outcomes in patients with diabetes. For more information: Betul Ibis, MD, can be reached at [email protected].
Diabetes 1997;46:615-21.ArticlePubMed 27
These substances are known to play a positive role in several functions in the body
US$ 21.68
US$ 29.04
US$ 26.20
US$ 26.17
